Clinical Trials Browser

Phase 1/2 × TAK-981 × Clear all

NCT04381650 2025-12-10

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Phase 1/2 Completed

161 enrolled 44 charts

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT03648372 2024-11-19

A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System

Phase 1/2 Terminated

109 enrolled 54 charts

LymphoidOther hematologic neoplasm

Lymphoma, Neoplasms, Hematologic Neoplasms

NCT04074330 2024-06-14

A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Phase 1/2 Terminated

38 enrolled 44 charts

Lymphoma, Non-Hodgkin